作者: Angela Gause , Armin Schnabel
DOI: 10.1007/S00063-003-1292-7
关键词:
摘要: Due to the partial elucidation of immunopathogenesis chronic inflammatory diseases during last years, clinical rheumatology has made a rapid development, which by consequent use immunomodulatory therapies including recombinant proteins (biologicals) led significantly ameliorated prognosis these diseases. On this basis, new research projects are continuously performed in fields pathogenesis, drug outcome and therapy studies. New developments imaging techniques serologic testing facilitate better classification definition disease activity remission criteria. The current state field rheumatoid arthritis spondylarthropathies with its consequences is reviewed article on basis most recent data available.